Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Hepatitis B
2021
Africa
Americas
Clear all
Type of publications
NITAG documentation
(78)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Africa
(18)
Americas
(64)
Europe
(77)
South-East Asia
(2)
Western Pacific
(14)
Countries
Argentina
(1)
Bolivia
(2)
Burkina Faso
(2)
Canada
(16)
Chile
(9)
Nigeria
(1)
Senegal
(2)
Uganda
(12)
United States of America
(36)
Diseases
COVID-19
(81)
Hepatitis B
(1)
Ebola
(1)
HIV / AIDS
(1)
Human papillomavirus (HPV)
(6)
Malaria
(1)
Meningococcal disease
(1)
Poliomyelitis
(2)
Rotavirus
(5)
Tetanus
(2)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Ethical issues
(2)
Target population
Adults
(3)
All age groups
(2)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2021
(82)
2024
(1)
2023
(20)
2022
(67)
2020
(66)
2019
(2)
2018
(6)
2017
(1)
2016
(6)
2015
(2)
2014
(1)
2012
(2)
2011
(4)
2009
(1)
2008
(2)
2006
(3)
2005
(1)
2003
(2)
2002
(1)
2000
(2)
1997
(1)
82 results found
2021
∙
NACI
NACI Rapid Response: Interchangeability of Authorized COVID-19 Vaccines - 01 June 2021
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
2021
NITAG-BF recommendation on the introduction of HEPATITIS B vaccine at birth in routine vaccination in Burkina Faso
2021
∙
ACIP
Overview of Janssen’s Single-Dose COVID-19 Vaccine, Ad26.COV2.S
2021
∙
NACI
Rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines
2021
∙
CoNaIn
Recommendation on the administration of additional doses for vaccination against COVID-19
2021
∙
NACI
Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5-11 years of age
2021
∙
UNITAG
Recommendation report on prioritisation of risk groups in Uganda
2021
∙
UNITAG
Recommendation Report: Allocation Strategy for the Multiple COVID-19 Vaccines in Uganda
2021
∙
UNITAG
Recommendation Report: The Use of the Inactivated SARS-CoV-2 BBIBP-CORV-CorV Sinopharm Vaccine
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register